Wellington Management Group LLP lifted its stake in shares of Cigna Group (NYSE:CI – Free Report) by 4.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 62,855 shares of the health services provider’s stock after buying an additional 2,584 shares during the period. Wellington Management Group LLP’s holdings in Cigna Group were worth $17,328,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of the company. Kingsview Wealth Management LLC acquired a new position in Cigna Group in the 2nd quarter worth about $10,291,000. Beacon Pointe Advisors LLC bought a new position in Cigna Group in the second quarter valued at about $11,015,000. Livforsakringsbolaget Skandia Omsesidigt acquired a new stake in shares of Cigna Group during the second quarter valued at about $3,037,000. Twin Lakes Capital Management LLC bought a new stake in shares of Cigna Group during the second quarter worth about $174,000. Finally, Rakuten Investment Management Inc. bought a new stake in shares of Cigna Group during the second quarter worth about $12,046,000. 86.99% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
CI has been the subject of a number of research reports. Sanford C. Bernstein raised their price objective on shares of Cigna Group from $371.00 to $381.00 and gave the company an “outperform” rating in a report on Thursday, July 9th. UBS Group boosted their target price on shares of Cigna Group from $375.00 to $400.00 and gave the stock a “buy” rating in a report on Friday, May 22nd. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 29th. Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a report on Thursday, August 27th. Finally, Jefferies Financial Group cut shares of Cigna Group from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $336.00 to $307.00 in a research note on Tuesday, August 4th. Fifteen analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $339.45.
Cigna Group Stock Performance
Shares of CI stock opened at $282.24 on Monday. The stock has a market capitalization of $74.58 billion, a PE ratio of 11.68, a PEG ratio of 0.97 and a beta of 0.31. The business’s 50 day simple moving average is $283.51 and its 200 day simple moving average is $281.00. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.76 and a quick ratio of 0.76. Cigna Group has a one year low of $239.51 and a one year high of $315.47.
Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The firm had revenue of $70.04 billion during the quarter, compared to analyst estimates of $70.14 billion. During the same quarter last year, the business earned $7.20 EPS. The company’s revenue was up 6.7% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, research analysts forecast that Cigna Group will post 30.51 earnings per share for the current year.
Cigna Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be issued a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 annualized dividend and a yield of 2.2%. Cigna Group’s payout ratio is presently 25.82%.
Insiders Place Their Bets
In other news, CAO Jamie Kates sold 899 shares of Cigna Group stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Nicole Jones sold 2,677 shares of the business’s stock in a transaction dated Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the transaction, the insider directly owned 25,880 shares in the company, valued at $7,236,306.80. This represents a 9.37% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 23,012 shares of company stock worth $6,386,550 in the last ninety days. Insiders own 0.60% of the company’s stock.
Cigna Group Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Further Reading
- Five stocks we like better than Cigna Group
- AI Token Costs Are Changing the Hardware vs. Software Debate
- 3 ETFs That Could Move as Rate Expectations Shift
- 3 Stocks With September Catalysts Investors Shouldn’t Ignore
- Ollie’s Bargain Outlet Stock Falls on Weak Comps Despite Margin Gains
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
